A carregar...
Lyn regulates creatine uptake in an imatinib-resistant CML cell line
BACKGROUND: Imatinib mesylate (imatinib) is the first-line treatment for newly diagnosed chronic myeloid leukemia (CML) due to its remarkable hematologic and cytogenetic responses. We previously demonstrated that the imatinib-resistant CML cells (Myl-R) contained elevated Lyn activity and intracellu...
Na minha lista:
| Publicado no: | Biochim Biophys Acta Gen Subj |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7055176/ https://ncbi.nlm.nih.gov/pubmed/31881245 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbagen.2019.129507 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|